Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products. The company manufactures and sells plastic consumables, which are used in automated systems/instruments; reagents; and automated nucleic acid extraction systems. It also offers geneLEAD, an instrument for molecular testing; LecChip series for research; and extraction reagents for nucleic acid extraction and biochemical testing. In addition, the company is involved in research and development of automated technologies support for the in vitro diagnosis testing market, including genetic and protein tests. The company was incorporated in 1985 and is headquartered in Matsudo, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $1.45 | N/A |
Market Cap | $40.10M | N/A |
Shares Outstanding | 27.63M | -0.01% |
Employees | 199.00 | N/A |
Shareholder Equity | 5.22B | -19.81% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.03 | N/A |
P/S Ratio | 1.19 | N/A |
P/B Ratio | 0.01 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0016 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $33.75M | N/A |
Earnings | -$8.47M | N/A |
EPS | -47.93 | N/A |
Earnings Yield | -33.03 | N/A |
Gross Margin | 0.2557 | N/A |
Operating Margin | -0.2108 | N/A |
Net income margin | -0.2509 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $62.41M | N/A |
Total Debt | $24.72M | N/A |
Cash on Hand | $15.64M | N/A |
Debt to Equity | 0.0056 | 15.57% |
Cash to Debt | 0.6327 | -7.97% |
Current Ratio | $2.93 | -7.15% |